TY - JOUR
T1 - Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension
T2 - The NHLBI Family Heart Study
AU - Tang, Weihong
AU - Pankow, James S.
AU - carr, J. Jeffrey
AU - Tracy, Russell P.
AU - Bielinski, Suzette J.
AU - North, Kari E.
AU - Hopkins, Paul N.
AU - Kraja, Aldi T.
AU - Arnett, Donna K.
PY - 2007/10/26
Y1 - 2007/10/26
N2 - Background: Data accumulated from mouse studies and in vitro studies of human arteries support the notion that soluble intercellular adhesion molecule-1 (sICAM-1) and monocyte chemoattractant protein-1 (MCP-1) play important roles in the inflammation process involved in atherosclerosis. However, at the population level, the utility of sICAM-1 and MCP-1 as biomarkers for subclinical atherosclerosis is less clear. In the follow-up exam of the NHLBI Family Heart Study, we evaluated whether plasma levels of sICAM-1 and MCP-1 were associated with coronary artery calcification (CAC), a measure of the burden of coronary atherosclerosis. Methods: CAC was measured using the Agatston score with multidetector computed tomography. Information on CAC and MCP-1 was obtained in 2246 whites and 470 African Americans (mean age 55 years) without a history of coronary heart disease (CHD). Information on sICAM-1 was obtained for white participants only. Results: In whites, after adjustment for age and gender, the odds ratios (ORs) of CAC (CAC < 0) associated with the second, third, fourth, and fifth quintiles of sICAM-1 compared to the first quintile were 1.22 (95% confidence interval [CI]: 0.91 - 1.63), 1.15 (0.84 - 1.58), 1.49 (1.09 - 2.05), and 1.72 (1.26 - 2.36) (p = 0.0005 for trend test), respectively. The corresponding ORs for the second to fifth quintiles of MCP-1 were 1.26 (0.92 - 1.73), 0.99 (0.73 - 1.34), 1.42 (1.03 - 1.96), and 2.00 (1.43 - 2.79) (p < 0.0001 for trend test), respectively. In multivariable analysis that additionally adjusted for other CHD risk factors, the association of CAC with sICAM-1 and MCP-1 was attenuated and no longer statistically significant. In African Americans, the age and gender-adjusted ORs of CAC associated with the second and third tertiles of MCP-1 compared to the first tertile were 1.16 (0.64 - 2.08) and 1.25 (0.70 - 2.23) (p = 0.44 for trend test), respectively. This result did not change materially after additional adjustment for other CHD risk factors. Test of race interaction showed that the magnitude of association between MCP-1 and CAC did not differ significantly between African Americans and whites. Similar results were obtained when CAC ≥ 10 was analyzed as an outcome for both MCP-1 and sICAM-1. Conclusion: This study suggests that sICAM-1 and MCP-1 are biomarkers of coronary atherosclerotic burden and their association with CAC was mainly driven by established CHD risk factors.
AB - Background: Data accumulated from mouse studies and in vitro studies of human arteries support the notion that soluble intercellular adhesion molecule-1 (sICAM-1) and monocyte chemoattractant protein-1 (MCP-1) play important roles in the inflammation process involved in atherosclerosis. However, at the population level, the utility of sICAM-1 and MCP-1 as biomarkers for subclinical atherosclerosis is less clear. In the follow-up exam of the NHLBI Family Heart Study, we evaluated whether plasma levels of sICAM-1 and MCP-1 were associated with coronary artery calcification (CAC), a measure of the burden of coronary atherosclerosis. Methods: CAC was measured using the Agatston score with multidetector computed tomography. Information on CAC and MCP-1 was obtained in 2246 whites and 470 African Americans (mean age 55 years) without a history of coronary heart disease (CHD). Information on sICAM-1 was obtained for white participants only. Results: In whites, after adjustment for age and gender, the odds ratios (ORs) of CAC (CAC < 0) associated with the second, third, fourth, and fifth quintiles of sICAM-1 compared to the first quintile were 1.22 (95% confidence interval [CI]: 0.91 - 1.63), 1.15 (0.84 - 1.58), 1.49 (1.09 - 2.05), and 1.72 (1.26 - 2.36) (p = 0.0005 for trend test), respectively. The corresponding ORs for the second to fifth quintiles of MCP-1 were 1.26 (0.92 - 1.73), 0.99 (0.73 - 1.34), 1.42 (1.03 - 1.96), and 2.00 (1.43 - 2.79) (p < 0.0001 for trend test), respectively. In multivariable analysis that additionally adjusted for other CHD risk factors, the association of CAC with sICAM-1 and MCP-1 was attenuated and no longer statistically significant. In African Americans, the age and gender-adjusted ORs of CAC associated with the second and third tertiles of MCP-1 compared to the first tertile were 1.16 (0.64 - 2.08) and 1.25 (0.70 - 2.23) (p = 0.44 for trend test), respectively. This result did not change materially after additional adjustment for other CHD risk factors. Test of race interaction showed that the magnitude of association between MCP-1 and CAC did not differ significantly between African Americans and whites. Similar results were obtained when CAC ≥ 10 was analyzed as an outcome for both MCP-1 and sICAM-1. Conclusion: This study suggests that sICAM-1 and MCP-1 are biomarkers of coronary atherosclerotic burden and their association with CAC was mainly driven by established CHD risk factors.
UR - http://www.scopus.com/inward/record.url?scp=38349182254&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38349182254&partnerID=8YFLogxK
U2 - 10.1186/1471-2261-7-30
DO - 10.1186/1471-2261-7-30
M3 - Article
C2 - 17963506
AN - SCOPUS:38349182254
SN - 1471-2261
VL - 7
JO - BMC Cardiovascular Disorders
JF - BMC Cardiovascular Disorders
M1 - 30
ER -
